Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
11639325-43-1----[1] 254
25-probe cocktail----[1] 254
3A novel synthetic, orally-administered, non-peptide small molecule, which acts as----[1] 254
4AFAMELANOTIDE[1] Afamelanotide[1] D10511 [1] MC1R 💬[2] Melanogenesis, Neuroactive ligand-receptor interaction 💬[2] 159, 254
5Afamelanotide Implant[1] Afamelanotide[1] D10511 [1] MC1R 💬[2] Melanogenesis, Neuroactive ligand-receptor interaction 💬[1] 254
6ALN-60519----[1] 254
7ALN-AS1----[1] 254
8CAS # in D.3.9.1 for Sodium Salt. CAS number 1639325-43-1 (Parent Acid)----[1] 254
9CAS# in D.3.9.1 for Sodium Salt. CAS number 1639325-43-1 (Parent Acid)----[1] 254
10Chlorpromazine[1] Chlorpromazine[1] D00270 [13] ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
DRD2,
HRH1,
HTR2A,
HTR2B,
HTR2C 💬		[22] Alcoholism, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 254
11Chlorpromazine Hydrochloride[1] Chlorpromazine[1] D00270 [13] ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
DRD2,
HRH1,
HTR2A,
HTR2B,
HTR2C 💬		[22] Alcoholism, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 254
12Cimetidine[1] Cimetidine[1] D00295 [1] HRH2 💬[3] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬[2] 2, 254
13Colestipol[1] Colestipol[1] D07771 --[1] 254
14COLESTYRAMINE[1] Cholestyramine---[1] 254
15Concentration unit: mg milligram(s)----[1] 254
16CUV1647----[1] 254
17Cysteine[1] Cysteine---[10] 13, 19, 34, 84, 85, 88, 90, 254, 296, 310
18Cysteine hydrochloride[1] Cysteine---[1] 254
19Deferasirox[1] Deferasirox[1] D03669 --[3] 254, 284, 286
20Dersimelagon----[2] 51, 254
21DISC-1459----[1] 254
22Exjade[1] Deferasirox[1] D03669 --[3] 254, 284, 286
23Givosiran[1] Givosiran[1] D11702 [1] ALAS1 💬[4] Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬[1] 254
24Givosiran (ALN-AS1)[1] Givosiran[1] D11702 [1] ALAS1 💬[4] Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬[1] 254
25Heme arginate[1] Heme arginate---[1] 254
26Hemin[1] Hemin[1] D10003 [2] ALAS1,
ALAS2 💬		[4] Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬[1] 254
27Hemin for injection[1] Hemin[1] D10003 [2] ALAS1,
ALAS2 💬		[4] Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬[1] 254
28Hydroxychloroquine[1] Hydroxychloroquine[1] D08050 --[27] 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299
29Iron[1] Iron---[6] 18, 96, 97, 238, 254, 284
30Isoniazid[1] Isoniazid[1] D00346 --[1] 254
31Luteinizing hormone[1] Luteinizing hormone---[1] 254
32Luteinizing hormone-releasing factor[1] Luteinizing hormone---[1] 254
33MT-7117----[2] 51, 254
34MT-7117 High Dose----[1] 254
35MT-7117 Low Dose----[1] 254
36Nle4,D-Phe7]-a-melanocyte stimulating hormone or NDP-a-MSH----[1] 254
37Nle4-D-Phe7-alpha-MSH----[1] 254
38Oral Iron[1] Iron---[2] 97, 254
39Panhematin[1] Hemin[1] D10003 [2] ALAS1,
ALAS2 💬		[4] Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬[1] 254
40Porphobilinogen[1] Porphobilinogen---[1] 254
41Questran[1] Cholestyramine---[4] 93, 254, 297, 338
42RAAV2/5-PBGD vector dosage 1----[1] 254
43RAAV2/5-PBGD vector dosage 2----[1] 254
44RAAV2/5-PBGD vector dosage 3----[1] 254
45RAAV2/5-PBGD vector dosage 4----[1] 254
46Recombinant human porphobilinogen deaminase (Porphozym)[1] Porphobilinogen---[1] 254
47SCENESSE[1] Afamelanotide[1] D10511 [1] MC1R 💬[2] Melanogenesis, Neuroactive ligand-receptor interaction 💬[3] 159, 161, 254
48Sterile Normal Saline (0.9% NaCl)----[2] 62, 254
49Tin mesoporphyrin[1] Stannsoporfin[1] D05922 [2] HMOX1,
HMOX2 💬		[10] Chemical carcinogenesis - reactive oxygen species, Ferroptosis, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatocellular carcinoma, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Pathways in cancer, Porphyrin metabolism 💬[1] 254